Trial on the corona virus vaccine AstraZeneca has been stopped in the UK. Oxford University, which developed the vaccine, said on Tuesday that it has a possible association with blood clotting (blood clot). A statement from the university said, “However, there is no security threat to children on clinical trials, but we are waiting for further information from the British regulator MHRA.” Parents and children should visit their schedule and in case of any doubt, they can contact the trial site.
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) is one of the regulatory bodies in the world currently analyzing data on AstraZeneca’s vaccine rollout to find out whether vaccines and blood clots are related Or not. Significantly, in many countries of Europe, including Norway, the vaccine was temporarily banned after the complaint of blood clots.
The World Health Organization (WHO) and the European Medicines Agency (EMA) will reveal their findings later this week. This new case has come to light after the controversy over the vaccine’s failure to deliver the vaccine on time, as promised to the European Union, and the effectiveness of the vaccine. MHRA reported at the end of the week that there have been 30 reported cases of blood clotting while applying 18 million doses in the UK, seven of which are serious. The European Medicines Agency said on Tuesday, “It has not reached a definite conclusion yet and the review is still on.”
(This news has not been edited by the NewsBust team. It has been published directly from the Syndicate feed.)